HIGHLIGHTS
- who: ufeffKeijiufeff ufeffHiraiufeff from the Medical University of Graz, Austria have published the Article: Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease, in the Journal: (JOURNAL)
- what: The results of this study demonstrated that roxadustat improved anemia and reduced serum cholesterol and triglyceride levels in patients who were not undergoing renal replacement therapy after changing from ESA treatment. This study had several advantages over the previously reported study . By contrast, in the present study, roxadustat`s effects on anemia, iron metabolism, renal function, proteinuria, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.